Disclosed is a pharmaceutical composition for suppressing pain in joint disorders, said composition comprising a pharmaceutically allowable carrier and hyaluronic acid crosslinked by means of cyclizing a double bond of the cinnamic acid portion of a partially amidated hyaluronic acid represented by general formula 1, [Ar-CH=CH-COO-(CH